Toxicological Research · 2011 · 15 citations · 19 references
MedicineImmunologyPharmacologyImmunopathologyInflammationInnate ImmunityAnti-inflammatory PharmacologyInflammation PharmacologyInflammatory Cell ResponsesInflammatory ProcessesInflammatory SignalingNeuroinflammationAnti-inflammatory Therapeutics
The effect of DHU001, a mixed herbal formula consisted of 7 types aqueous extracts for various respiratory disorders were evaluated on the formalin-induced paw chronic inflammation in mice after oral administration. Mice were subaponeurotically injected in the left hind paw with 0.02 ml of 3.75% formalin, then subjected to 500, 250 and 125 mg/kg of DHU001 oral administration, once a day for 10 days during which then the hind-paw thickness and volume were measured daily. The paw wet-weight, histological profiles, histomorphometrical analyses and paw tumor necrosis factor (TNF)-α contents were conducted at termination. After two formalin treatments, a marked increase in the paw thickness and volume was detected in the formalin-injected control as compared with that in the intact control, plus at the time of sacrifice the paw wet-weights, paw TNF-α contents were also dramatically increased with severe chronic inflammation signs at histopathological observations. However, these formalin-induced chronic inflammatory changes were dramatically decreased by treatment of dexamethasone and all three different dosages of DHU001. DHU001 has favorable effects on formalin-induced chronic inflammation mediated by TNF-α suppression, and DHU001 may represent an alternative approach for the treatment of chronic inflammatory diseases.
19
Maria Schäfers, Doo H. Lee, Dominik Brors et al. · Journal of Neuroscience · 2003 · 266 citations · Full text
Vanu Ramprasath, Palanivelu Shanthi, Panchanatham Sachdanandam · Biological and Pharmaceutical Bulletin · 2006 · 156 citations · Full text